These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 17661009

  • 1. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.
    Schäfer SA, Tschritter O, Machicao F, Thamer C, Stefan N, Gallwitz B, Holst JJ, Dekker JM, 't Hart LM, Nijpels G, van Haeften TW, Häring HU, Fritsche A.
    Diabetologia; 2007 Dec; 50(12):2443-50. PubMed ID: 17661009
    [Abstract] [Full Text] [Related]

  • 2. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.
    Pilgaard K, Jensen CB, Schou JH, Lyssenko V, Wegner L, Brøns C, Vilsbøll T, Hansen T, Madsbad S, Holst JJ, Vølund A, Poulsen P, Groop L, Pedersen O, Vaag AA.
    Diabetologia; 2009 Jul; 52(7):1298-307. PubMed ID: 19288077
    [Abstract] [Full Text] [Related]

  • 3. A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion.
    Schäfer SA, Müssig K, Staiger H, Machicao F, Stefan N, Gallwitz B, Häring HU, Fritsche A.
    Diabetologia; 2009 Jun; 52(6):1075-82. PubMed ID: 19330314
    [Abstract] [Full Text] [Related]

  • 4. A Reduced Incretin Effect Mediated by the rs7903146 Variant in the TCF7L2 Gene Is an Early Marker of β-Cell Dysfunction in Obese Youth.
    Galderisi A, Tricò D, Pierpont B, Shabanova V, Samuels S, Dalla Man C, Galuppo B, Santoro N, Caprio S.
    Diabetes Care; 2020 Oct; 43(10):2553-2563. PubMed ID: 32788279
    [Abstract] [Full Text] [Related]

  • 5. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion.
    Wang J, Kuusisto J, Vänttinen M, Kuulasmaa T, Lindström J, Tuomilehto J, Uusitupa M, Laakso M.
    Diabetologia; 2007 Jun; 50(6):1192-200. PubMed ID: 17437080
    [Abstract] [Full Text] [Related]

  • 6. Impact of TCF7L2 rs7903146 on insulin secretion and action in young and elderly Danish twins.
    Wegner L, Hussain MS, Pilgaard K, Hansen T, Pedersen O, Vaag A, Poulsen P.
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4013-9. PubMed ID: 18611970
    [Abstract] [Full Text] [Related]

  • 7. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion.
    Kirchhoff K, Machicao F, Haupt A, Schäfer SA, Tschritter O, Staiger H, Stefan N, Häring HU, Fritsche A.
    Diabetologia; 2008 Apr; 51(4):597-601. PubMed ID: 18264689
    [Abstract] [Full Text] [Related]

  • 8. Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele.
    Færch K, Pilgaard K, Knop FK, Hansen T, Pedersen O, Jørgensen T, Holst JJ.
    Diabetes Obes Metab; 2013 Jan; 15(1):91-5. PubMed ID: 22862926
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The T-allele of TCF7L2 rs7903146 associates with a reduced compensation of insulin secretion for insulin resistance induced by 9 days of bed rest.
    Alibegovic AC, Sonne MP, Højbjerre L, Hansen T, Pedersen O, van Hall G, Holst JJ, Stallknecht B, Dela F, Vaag A.
    Diabetes; 2010 Apr; 59(4):836-43. PubMed ID: 20107109
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association between allelic variants in the glucagon-like peptide 1 and cholecystokinin receptor genes with gastric emptying and glucose tolerance.
    Anderson B, Carlson P, Laurenti M, Vella A, Camilleri M, Desai A, Feuerhak K, Bharucha AE.
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13724. PubMed ID: 31691451
    [Abstract] [Full Text] [Related]

  • 13. Potential role of TCF7L2 gene variants on cardiac sympathetic/parasympathetic activity.
    Boccardi V, Ambrosino I, Papa M, Fiore D, Rizzo MR, Paolisso G, Barbieri M.
    Eur J Hum Genet; 2010 Dec; 18(12):1333-8. PubMed ID: 20648057
    [Abstract] [Full Text] [Related]

  • 14. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
    Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D, Diabetes Prevention Program Research Group.
    N Engl J Med; 2006 Jul 20; 355(3):241-50. PubMed ID: 16855264
    [Abstract] [Full Text] [Related]

  • 15. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
    Villareal DT, Robertson H, Bell GI, Patterson BW, Tran H, Wice B, Polonsky KS.
    Diabetes; 2010 Feb 20; 59(2):479-85. PubMed ID: 19934000
    [Abstract] [Full Text] [Related]

  • 16. Metabolic, hormonal characteristics and genetic variants of TCF7L2 associated with development of gestational diabetes mellitus in Mexican women.
    Reyes-López R, Pérez-Luque E, Malacara JM.
    Diabetes Metab Res Rev; 2014 Nov 20; 30(8):701-6. PubMed ID: 24639413
    [Abstract] [Full Text] [Related]

  • 17. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance.
    Damcott CM, Pollin TI, Reinhart LJ, Ott SH, Shen H, Silver KD, Mitchell BD, Shuldiner AR.
    Diabetes; 2006 Sep 20; 55(9):2654-9. PubMed ID: 16936218
    [Abstract] [Full Text] [Related]

  • 18. Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice.
    da Silva Xavier G, Mondragon A, Sun G, Chen L, McGinty JA, French PM, Rutter GA.
    Diabetologia; 2012 Oct 20; 55(10):2667-2676. PubMed ID: 22717537
    [Abstract] [Full Text] [Related]

  • 19. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
    Meier JJ, Gallwitz B, Askenas M, Vollmer K, Deacon CF, Holst JJ, Schmidt WE, Nauck MA.
    Diabetologia; 2005 Sep 20; 48(9):1872-81. PubMed ID: 16010522
    [Abstract] [Full Text] [Related]

  • 20. The enteroinsular axis may mediate the diabetogenic effects of TCF7L2 polymorphisms.
    Nauck MA, Meier JJ.
    Diabetologia; 2007 Dec 20; 50(12):2413-6. PubMed ID: 17898988
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.